NOVAVAX INC: cash_and_equivalents
| Value | {"amount": 106307000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1b34e63c-2f9b-4949-b921-6d83ba8ad621
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-18-014686Retrieved: 2026-08-19T09:41:02.413114+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/cash-and-equivalents/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1b34e63c-2f9b-4949-b921-6d83ba8ad621
History
- no predecessors — first report